|
Match
|
Document |
Document Title |
|
|
US20090306016 |
FATTY ACID AMIDE HYDROLASE INHIBITORS
Disclosed are compounds of formula R—X—Y that may be used to inhibit the action of fatty acid amide hydrolase (FAAH). Inhibition of fatty acid amide hydrolase (FAAH) will slow the normal...
|
|
|
US20090221714 |
Pharmaceutical Composition for Prevention and Treatment of Drug or Alcohol Addiction or Bipolar Disorder Using Sodium Phenylbutyrate
Provided is a pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder, comprising sodium phenylbutyrate (PBA). The pharmaceutical composition for...
|
|
|
US20090221702 |
COMPOUNDS
The present invention provides the use of a compound of the Formula: (I) wherein R 1 is C 1-5 alkoxy, OCOC 1-3 Alkyl, O(CH 2 ) 2 O(CH 2 ) 2 O(CH 2 ) 2 OMe, O(CH 2 ) 2 O(CH 2 ) 2 O(CH 2 ) 2 OH or...
|
|
|
US20090209651 |
USE OF 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL) PROPANE-1-ONE FOR IMPROVED SKIN CONTOURING OR AGAINST CELLULITE
A cosmetic or dermatological preparation which is suitable for application to skin and comprises 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propane-1-
one in a concentration which is...
|
|
|
US20090208425 |
TRANSMUCOSAL ADMINISTRATION OF 2,3-DIMETHOXY-5-METHYL-6-(10-HYDROXYDECYL)-1,4-BENZOQUINONE
Use of idebenone for the preparation of a medicament for transmucosal administration.
|
|
|
US20090203653 |
Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors
The invention describes novel compositions comprising at least one apocynin compound or a pharmaceutically acceptable salt thereof, and at least one nitric oxide donor, and, optionally, at least...
|
|
|
US20090149550 |
WRINKLE REDUCTION AGENT, LIPOLYSIS ACCELERATOR, COMPOSITION FOR EXTERNAL USE ON SKIN, AND FOOD OR BEVERAGE COMPOSITION
An antiwrinkle agent, lipolysis promoter, external composition for skin, and food and beverage composition having for an active ingredient thereof a compound represented by general formula (1):
...
|
|
|
US20090098097 |
COMPOSITION FOR NORMALIZING BLOOD PRESSURE
The present invention aims to provide a composition suitable for normalizing the blood pressure, which is useful as food, health food, supplement, nutritional supplement, food for specified health...
|
|
|
US20090042946 |
METHOD AND KIT FOR CONTROLLING BLEEDING
Methods and kits for controlling bleeding from a disrupted blood vessel, wherein a vanilloid receptor agonist is administered to the site of the disruption of the blood vessel in a quantity...
|
|
|
US20090012107 |
Antiviral Compounds and Methods of Using Thereof
Disclosed herein are compounds which exhibit antiviral activity against a plurality of viruses belonging to different families such as Bornaviridae, Filoviridae, Paramyxoviridae, Rhabdoviridae,...
|
|
|
US20090011059 |
Ginger Extract For Inhibiting Human Drug Transporters
The present invention relates to the use of a ginger extract on its own or in combination with pharmaceutical compositions for inhibiting human drug transporters for positively influencing the oral...
|
|
|
US20090004304 |
COMPOSITION COMPRISING BIOACTIVE SUBSTANCE
The present invention provides a powder superior in water-dispersibility/solubility, workability and tabletability, which contains an oil component containing a bioactive substance, a water-soluble...
|
|
|
US20080312333 |
Agent for Preventing/Ameliorating Life Style-Related Diseases Containing Turmeric Essential Oil Component
The present invention has its object to provide an agent for preventing and/or ameliorating life style-related diseases which contains, as an active ingredient, a substance derived from a safe food...
|
|
|
US20080300304 |
Ginger Fraction For Inhibiting Human Cyp Enzymes
The present invention relates to a process for preparing a ginger fraction, the fraction prepared by this process and the use thereof on its own or combined with drugs for inhibiting human...
|
|
|
US20080260659 |
Compositions
The invention is directed to personal care products and compositions that comprise at least one preservative compound selected from the group consisting of benzoic acid, p-hydroxy-benzoic acid,...
|
|
|
US20080255097 |
Methods for the Treatment of Substance Abuse and Dependence
The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of...
|
|
|
US20080227866 |
Hydroxyphenylalkadiones and Their Use for Masking Bitter Taste and/or for Intensifying Sweet Taste
The use
of a hydroxyphenylalkadione derivative of the formula (I)
wherein, for X, a and Y:
X is a —CH 2 —, —NH— or —O— group, Y is a —CH 2 — group and a is...
|
|
|
US20080221029 |
METHODS FOR TREATMENT OF THIOL-CONTAINING COMPOUND DEFICIENT CONDITIONS
Certain embodiments in the present invention provide for methods for therapy of lung diseases and other conditions such as infection are provided. In certain embodiments, the methods comprise one...
|
|
|
US20080207560 |
Composition For External Use
An object of the present invention is to provide a composition for external use in which the percutaneous absorbability of vitamin A, vitamin A derivative(s), vitamin C, specific vitamin C...
|
|
|
US20080206290 |
COSMETIC COMBINATION PRODUCT FOR IMPROVING APPEARANCE
A cosmetic combination product, wherein the product comprises at least two components selected from (a) one or more dietary supplements, (b) one or more cosmetic preparations for topical...
|
|
|
US20080193573 |
Extracts and methods comprising curcuma species
The present invention relates to extracts of curcuma species plant material using supercritical CO 2 extraction methods, methods of treating a subject suffering from suffering from amyloid...
|
|
|
US20080160116 |
Compositions and Methods Comprising Zingiber Species
An aspect of the present invention relates to compositions comprising a gingerol, for example, compositions comprising gingerol in an amount greater than about 2% by weight. In some aspects of the...
|
|
|
US20080145449 |
Thiol reactive agents as a therapeutic modality
A patient with a disease associated with a receptor having a cysteine residue is treated with a thiol reactive agent. The diseases include neurodegenerative diseases. Diseases characterized by...
|
|
|
US20080125495 |
Ameliorant For Renal Insufficiency
The present invention relates to an agent for improving renal dysfunction comprising as an active ingredient a compound represented by the following formula (1):
wherein each R 1 , R 2 , and R 3...
|
|
|
US20080124412 |
Methods for reducing circulating glucose levels
The invention relates to methods of reducing circulating glucose levels with compositions obtained from botanical sources. More specifically, the invention relates to methods of treating...
|
|
|
US20080103103 |
Reagents and methods to treat ocular diseases and infection
The invention provides compositions and methods of treating an ocular condition by administering to an eye of a patient having an ocular condition an effective amount of a catechin or polyphenol....
|
|
|
US20080045591 |
Chemical Compounds
Compounds of general formula I:
wherein:
R 1 and R 2 are, independently of each other, selected from hydrogen, optionally substituted C 1-10 alkyl, optionally substituted —CO—(C 1-10...
|
|
|
US20080026063 |
Composition containing reduced coenzyme Q10 and production method thereof
The present invention provides a particulate composition wherein an oil component containing reduced coenzyme Q 10 is polydispersed forming a domain in a matrix containing a water-soluble...
|
|
|
US20080015249 |
CANCER TREATMENT COMPOSITIONS AND METHOD USING NATURAL PLANT ESSENTIAL OILS
Pharmaceutical compositions containing plant essential oils, natural or synthetic, or mixtures or derivatives thereof, for the prevention and treatment of soft tissue cancer in mammals.
|